Prevalence of Prediabetes and Diabetes and Metabolic Profile of Patients With Nonalcoholic Fatty Liver Disease (NAFLD)

OBJECTIVE Prediabetes and type 2 diabetes mellitus (T2DM) are believed to be common and associated with a worse metabolic profile in patients with nonalcoholic fatty liver disease (NAFLD). However, no previous study has systematically screened this population. RESEARCH DESIGN AND METHODS We studied the prevalence and the metabolic impact of prediabetes and T2DM in 118 patients with NAFLD. The control group comprised 20 subjects without NAFLD matched for age, sex, and adiposity. We measured 1 ) plasma glucose, insulin, and free fatty acid (FFA) concentration during an oral glucose tolerance test; 2 ) liver fat by magnetic resonance spectroscopy (MRS); 3 ) liver and muscle insulin sensitivity (euglycemic insulin clamp with 3-[ 3 H]glucose); and 4 ) indexes of insulin resistance (IR) at the level of the liver (HIR i = endogenous glucose production × fasting plasma insulin [FPI]) and adipose tissue (Adipo-IR i = fasting FFA × FPI). RESULTS Prediabetes and T2DM was present in 85% versus 30% in controls ( P P r = 0.34; P r = 0.57; P r = 0.35; P CONCLUSIONS Patients with NAFLD may benefit from early screening for T2DM, because the prevalence of abnormal glucose metabolism is much higher than previously appreciated. Regardless of glucose tolerance status, severe IR is common. In patients with T2DM, adipose tissue IR appears to play a major role in the severity of NAFLD.